CYP4Z1-Specific Polyclonal antibody

CYP4Z1-Specific Polyclonal Antibody for WB, ELISA

Host / Isotype

Rabbit / IgG

Reactivity

human

Applications

WB, ELISA

Conjugate

Unconjugated

Cat no : 20142-1-AP

Synonyms

CYP4A20, CYP4Z1, CYPIVZ1, Cytochrome P450 4Z1


☆大好評トライアルサイズ ¥20,000~! >>> 一次抗体特別価格キャンペーン開催中!


Tested Applications

Positive WB detected inMDA-MB-453s cells, HeLa cells

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:500-1:1000
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Published Applications

WBSee 2 publications below

Product Information

20142-1-AP targets CYP4Z1-Specific in WB, ELISA applications and shows reactivity with human samples.

Tested Reactivity human
Cited Reactivity human
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen Peptide 相同性解析による交差性が予測される生物種
Full Name cytochrome P450, family 4, subfamily Z, polypeptide 1
Calculated molecular weight 59 kDa
Observed molecular weight 59 kDa
GenBank accession numberNM_178134
Gene symbol CYP4Z1
Gene ID (NCBI) 199974
RRIDAB_10666432
Conjugate Unconjugated
Form Liquid
Purification MethodAntigen affinity purification
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.

Background Information

CYP4Z1 belongs to the cytochrome P450 family. CYP4Z1 catalyzes the reaction: RH + reduced flavoprotein + O2 = ROH + oxidized flavoprotein + H2O. This antibody is specific to CYP4Z1.

Protocols

Product Specific Protocols
WB protocol for CYP4Z1-Specific antibody 20142-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

SpeciesApplicationTitle
humanWB

Environ Toxicol

1-Benzylimidazole attenuates the stemness of breast cancer cells through partially targeting CYP4Z1

Authors - Hai Qin
humanWB

Mol Carcinog

HET0016 attenuates the stemness of breast cancer cells through targeting CYP4Z1.

Authors - Hai Liu